Smart Inhalers Market Size, Growth, Trends, Analysis, Challenges and Future Opportunities
Smart Inhalers Market Growth, Size, Trends Analysis - By Type, By Indication, By Distribution Channel, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jan-2025 | Report ID: MEDE2502 | Pages: 1 - 247 | Formats*: |
| Category : Medical Devices | |||
Smart Inhalers Market Introduction and Overview
According to SPER Market Research, the Global Smart Inhalers Market is estimated to reach USD 110.83 billion by 2034 with a CAGR of 19.65%.
The report includes an in-depth analysis of the Global Smart Inhalers Market, including market size and trends, product mix, Applications, and supplier analysis.
The market for smart inhalers was valued at USD 18.43 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 19.65% between 2025 and 2034. The market is anticipated to rise as a result of the increasing incidence of chronic respiratory diseases (CRDs) worldwide, the creation of goods with cutting-edge technology, and the expanding use of digital solutions in the healthcare industry. Furthermore, according to WHO predictions, by 2030, almost one in five fatalities globally would be attributable to potentially lethal respiratory diseases, such as tuberculosis, lung cancer, and COPD.
By Type Insights
The market is divided into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). In 2024, MDIs held the largest revenue share due to their ease of use and efficiency in delivering fixed doses through inhalation. In September 2022, OzUK Limited partnered with H&T Presspart to provide generic MDIs for COPD/Asthma applications.
By Indication Insights
The market is divided into COPD, asthma, and others. COPD had the largest revenue share in 2024 due to its global prevalence. The asthma segment is expected to grow significantly over the forecast period, driven by rising cases and increased demand for smart inhalers and innovative solutions.
By Distribution Channel Insights
The hospital pharmacies segment had the largest revenue share in 2024. They provide more flexibility, comfort, and convenience for buying smart inhalers for hospitalized patients. Rising cases of chronic respiratory illnesses have led to more patients in hospitals, making it easier for them to purchase smart inhalers nearby, boosting segment growth.
By End Use Insights
Hospitals had the biggest revenue share in 2024. Quick improvements in healthcare infrastructure, growing public-private partnerships, and better access to services are expected to greatly affect hospitals. They also quickly use smart inhaler technology for patients with respiratory diseases. The rising number of patients pushes hospitals to keep a large stock of various smart inhalers.
By Regional Insights
North America dominated the global smart inhalers market in 2024. Key factors for this growth include the region's strong healthcare infrastructure, rising cases of COPD and asthma, and the use of advanced medical devices. Regulatory bodies also support solutions for respiratory diseases.
Market Competitive Landscape
Key competitors in the respiratory industry are using collaborations, mergers and acquisitions, and new product development to grow their market share. Notable firms include Teva Pharmaceuticals, 3M, Novartis, Adherium, Propeller Health, and COHERO Health. These companies are using various strategies to gain an edge over rivals. Adherium Limited partnered with Trudell Medical in August 2022, combining Adherium's Hailie sensors with Trudell's U. S. operations and Aetonix's aTouchAway platform to assist COPD patients, aiming to improve patient outcomes and reduce readmissions.
Recent Developments:
- In April 2024, Adherium announced it received FDA clearance for its Hailie Smartinhaler with AstraZeneca’s Breztri and Airsupra inhalation devices. This clearance provides real-time insights through data collection into inhaler technique and medication usage.
- AstraZeneca and Honeywell formed a partnership in February 2022 to create new respiratory inhalers with propellant HFO-1234ze. This propellant has a Global Warming Potential (GWP) about 99.9% lower than current options, enhancing the company's market offerings.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type, By Indication, By Distribution Channel, By End Use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Presspart Verwaltungs GmbH, Personal Air Quality Systems Pvt Ltd, AptarGroup, Inc, Cognita Labs, Adherium, Amiko Digital Health Limited, Teva Pharmaceuticals Industries Ltd, ResMed, Novartis AG, Pneuma Respiratory Inc, 3M. |
Key Topics Covered in the Report:
- Global Smart Inhalers Market Size (FY’2021-FY’2034)
- Overview of Global Smart Inhalers Market
- Segmentation of Global Smart Inhalers Market By Type (Dry Powdered Inhalers, Metered Dose Inhalers)
- Segmentation of Global Smart Inhalers Market By Indication (Asthma, COPD, Others)
- Segmentation of Global Smart Inhalers Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
- Segmentation of Global Smart Inhalers Market By End Use (Hospitals, Homecare Settings, Others)
- Statistical Snap of Global Smart Inhalers Market
- Expansion Analysis of Global Smart Inhalers Market
- Problems and Obstacles in Global Smart Inhalers Market
- Competitive Landscape in the Global Smart Inhalers Market
- Details on Current Investment in Global Smart Inhalers Market
- Competitive Analysis of Global Smart Inhalers Market
- Prominent Players in the Global Smart Inhalers Market
- SWOT Analysis of Global Smart Inhalers Market
- Global Smart Inhalers Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTERs Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Smart Inhalers Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Smart Inhalers Market
7. Global Smart Inhalers Market, By Type (USD Million) 2021-2034
7.1. Dry Powdered Inhalers (DPIs)7.2. Metered Dose Inhalers (MDIs)
8. Global Smart Inhalers Market, By Indication (USD Million) 2021-2034
8.1. Asthma8.2. COPD8.3. Others
9. Global Smart Inhalers Market, By Distribution Channel (USD Million) 2021-2034
9.1. Hospital Pharmacies9.2. Retail Pharmacies9.3. Online Pharmacies
10. Global Smart Inhalers Market, By End Use (USD Million) 2021-2034
10.1. Hospitals10.2. Homecare Settings10.3. Others
11. Global Smart Inhalers Market (USD Million) 2021-2034
11.1. Global Smart Inhalers Market Size and Market Share
12. Global Smart Inhalers Market, By Region (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia12.1.2. China12.1.3. India12.1.4. Japan12.1.5. South Korea12.1.6. Rest of Asia-Pacific12.2. Europe12.2.1. France12.2.2. Germany12.2.3. Italy12.2.4. Spain12.2.5. United Kingdom12.2.6. Rest of Europe12.3. Middle East and Africa12.3.1. Kingdom of Saudi Arabia12.3.2. United Arab Emirates12.3.3. Qatar12.3.4. South Africa12.3.5. Egypt12.3.6. Morocco12.3.7. Nigeria12.3.8. Rest of Middle-East and Africa12.4. North America12.4.1. Canada12.4.2. Mexico12.4.3. United States12.5. Latin America12.5.1. Argentina12.5.2. Brazil12.5.3. Rest of Latin America
13. Company Profile
13.1. Presspart Verwaltungs GmbH13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments13.2. AptarGroup, Inc13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments13.3. Cognita Labs13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments13.4. Adherium13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments13.5. Amiko Digital Health Limited13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments13.6. Teva Pharmaceuticals Industries Ltd13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments13.7. ResMed13.7.1. Company details13.7.2. Financial outlook13.7.3. Product summary13.7.4. Recent developments13.8. Novartis AG13.8.1. Company details13.8.2. Financial outlook13.8.3. Product summary13.8.4. Recent developments13.9. Pneuma Respiratory Inc13.9.1. Company details13.9.2. Financial outlook13.9.3. Product summary13.9.4. Recent developments13.10. 3M13.10.1. Company details13.10.2. Financial outlook13.10.3. Product summary13.10.4. Recent developments13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Smart Inhalers Market is projected to reach USD 110.83 billion by 2034, growing at a CAGR of 19.65% during the forecast period.
Smart Inhalers Market grew in Market size from 2025. The Market is expected to reach USD 110.83 billion by 2034, at a CAGR of 19.65% during the forecast period.
Smart Inhalers Market CAGR of 19.65% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Smart Inhalers Market size is USD 110.83 billion from 2025 to 2034.
Smart Inhalers Market is covered By Type, By Indication, By Distribution Channel, By End Use
The North America is anticipated to have the highest Market share in the Smart Inhalers Market.
The Key players in the Market include Companies Covered Presspart Verwaltungs GmbH, Personal Air Quality Systems Pvt Ltd, AptarGroup, Inc, Cognita Labs, Adherium, Amiko Digital Health Limited, Teva Pharmaceuticals Industries Ltd, ResMed, Novartis AG, Pneuma Respiratory Inc, 3M.
The high cost of advanced diabetes drugs and the financial burden of treating diabetes remain major obstacles to market growth, despite the fact that numerous drugs have been approved for the condition and that governments and industry players are launching numerous initiatives.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
